Current perspectives on systems immunology approaches to rheumatic diseases. - Wikidata - wikimedia - TriplyDB

Current perspectives on systems immunology approaches to rheumatic diseases.

Current perspectives on systems immunology approaches to rheumatic diseases.

http://www.wikidata.org/entity/Q27687400

about

Applications of systems approaches in the study of rheumatic diseases.Advances in systems biology approaches for autoimmune diseases Type I interferon in the pathogenesis of lupus.Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures.Unifying immunology with informatics and multiscale biology.Advances in understanding the role of type I interferons in systemic lupus erythematosus.Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis.Mass cytometry identifies a distinct monocyte cytokine signature shared by clinically heterogeneous pediatric SLE patients.A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features.

P2860

Q27692558-2C623C7C-198F-44D8-A71F-0251CD50885E Q33619013-6D91DE30-9B20-4095-84B0-45D71528F5C1 Q33852174-D6F7A796-2744-4863-B365-958D3E6C96CE Q34149941-DBBFB6D0-95D8-4772-86F7-68813D379FF0 Q35134186-FA0D302B-A279-410E-9AE3-04E88EDA6625 Q38227972-25EED9BD-FD89-4E83-9FAA-515C6185DEF3 Q38777083-60471E82-6CF8-4C97-B9A9-87D62B873B3B Q40260152-C067F599-C74C-4E81-92A4-023A9417677D Q52593114-A77401A1-E8DD-46FC-9250-FB8DAB3DB870

P2860

Current perspectives on systems immunology approaches to rheumatic diseases.

http://www.wikidata.org/entity/Q27687400

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Current perspectives on systems immunology approaches to rheumatic diseases.

@ast

Current perspectives on systems immunology approaches to rheumatic diseases.

@en

Current perspectives on systems immunology approaches to rheumatic diseases.

@nl

type

label

Current perspectives on systems immunology approaches to rheumatic diseases.

@ast

Current perspectives on systems immunology approaches to rheumatic diseases.

@en

Current perspectives on systems immunology approaches to rheumatic diseases.

@nl

prefLabel

Current perspectives on systems immunology approaches to rheumatic diseases.

@ast

Current perspectives on systems immunology approaches to rheumatic diseases.

@en

Current perspectives on systems immunology approaches to rheumatic diseases.

@nl

P1433

Q27687400-1D6982DC-E4C9-49FC-8E77-A839839278F2

P1476

Q27687400-7F793722-2024-41D1-84E6-4B48F686650C

P2093

Q27687400-20FF51EC-ED46-4238-9D9F-A36E5106DB9D

Q27687400-6B93AA1B-53B1-4F0C-A8BF-E49F057FE074

Q27687400-B13DBE8D-911D-482D-B6D6-BC0137F47C5C

P2860

Q27687400-0B7E03AD-3C6F-4683-87F8-BF734C93910A

Q27687400-1F535283-C482-4FAF-9F2D-78C677CA009E

Q27687400-4422DE36-2EC2-418D-9D3E-6244F3344F39

Q27687400-476EA37F-0636-4618-86D4-20976FE4D037

Q27687400-4798275E-CE52-4054-857F-AB765D349DFC

Q27687400-47E23243-E48B-4562-A338-0A412FE22490

Q27687400-4C66E46B-CB27-4E85-881B-450D7D86804B

Q27687400-4C727546-8653-4729-8148-182125497B17

Q27687400-59155715-446F-496D-B7C4-1863B2F7C1C4

Q27687400-5D58B057-044E-451B-A873-818C60E77506

P304

Q27687400-588A0DF3-1739-4918-A566-A083CE007572

P31

Q27687400-B7191B3A-23FA-448A-86A2-60752E2C4ACD

P356

Q27687400-19580E66-1041-4E65-84DA-127F3D921550

P433

Q27687400-2BB6F216-6429-4725-BB35-F91FEFA29AEA

P478

Q27687400-22D51C0B-98AC-4BC7-A4ED-9DB886119A71

P50

Q27687400-9D66F41C-427F-4BDF-9D40-51529DDF2413

P577

Q27687400-1949CD76-B7F4-433B-92E2-E78E63280C9C

P5875

Q27687400-DB49C495-C435-4152-BD06-2E7B392A0495

P698

Q27687400-0C39D967-2FC8-4BBB-982D-116B7E580C84

P356

P1433

Arthritis & Rheumatology

P1476

Current perspectives on systems immunology approaches to rheumatic diseases.

@en

P2093

Laurent Chiche

http://www.w3.org/2001/XMLSchema#string

Noemie Jourde-Chiche

http://www.w3.org/2001/XMLSchema#string

Virginia Pascual

http://www.w3.org/2001/XMLSchema#string

P2860

Microarrays, deep sequencing and the true measure of the transcriptome

Cross-regulation of TNF and IFN-alpha in autoimmune diseases

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

Minimum information about a microarray experiment (MIAME)-toward standards for microarray data

A gene-expression signature as a predictor of survival in breast cancer

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus

Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus

An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity

An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity

P304

1407-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.37909

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

Damien Chaussabel

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264658092

http://www.w3.org/2001/XMLSchema#string

P698

23450649

http://www.w3.org/2001/XMLSchema#string